{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:40:05Z","timestamp":1750538405003,"version":"3.41.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We report the case of 69-year-old man referred for a stage IV pulmonary adenocarcinoma and presenting a decrease in visual acuity. An <jats:sup>18<\/jats:sup>F-FDG PET\/CT showed an intense and heterogeneous uptake of a mass in the sellar region. An MRI showed a pituitary macroadenoma associated with a large cyst on the left side, with necrosis zones and fluid level, compressing the optic chiasma. Endocrine testing showed a panhypopituitarism, and pathology confirmed a pituitary apoplexy in a gonadotropin-secreting macroadenoma. No malignant cells were detected. Molecular imaging could have an important role in the detection and characterization of pituitary tumors.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003710","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T22:04:49Z","timestamp":1621980289000},"page":"748-749","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Gonadotropin-Secreting Pituitary Macroadenoma Complicated With Hemorrhagic Apoplexy in 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"46","author":[{"given":"Sebastien","family":"Dejust","sequence":"first","affiliation":[{"name":"Unit\u00e9 de M\u00e9decine Nucl\u00e9aire, Institut Godinot"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedicte","family":"Decoudier","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie, H\u00f4pital Robert Debr\u00e9"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Higel","sequence":"additional","affiliation":[{"name":"Service de Radiologie"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude-Fabien","family":"Litre","sequence":"additional","affiliation":[{"name":"Service de Neuro-chirurgie, H\u00f4pital Maison Blanche"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Morland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.seminoncol.2018.09.002","article-title":"Cancer immunotherapy-associated hypophysitis","volume":"45","year":"2018","journal-title":"Semin Oncol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jfo.2009.04.019","article-title":"Apoplexie hypophysaire et baisse d\u2019acuit\u00e9 visuelle bilat\u00e9rale s\u00e9v\u00e8re : \u00e0 propos d\u2019un cas","volume":"32","year":"2009","journal-title":"J Fr Ophtalmol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.RLU.0000057554.55930.05","article-title":"Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma","volume":"28","year":"2003","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3171\/2014.10.JNS141720","article-title":"Apoplexy of pituitary adenomas: the perfect storm","volume":"122","year":"2015","journal-title":"J Neurosurg"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.110.083733","article-title":"Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00259-010-1571-5","article-title":"Incidental pituitary uptake on whole-body 18F-FDG PET\/CT: a multicentre study","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/RLU.0000000000003313","article-title":"Pituitary metastases discovered by 18F-FDG PET\/CT during other cancers monitoring: are there any differences of SUVs between benign and malignant diseases?","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"55544","DOI":"10.18632\/oncotarget.15417","article-title":"Evaluation of pituitary uptake incidentally identified on 18F-FDG PET\/CT scan","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2019.08.008","article-title":"The pituitary in nuclear medicine imaging","volume":"68","year":"2019","journal-title":"Eur J Intern Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/RLU.0000000000003101","article-title":"18F-FDG PET\/CT findings in a patient with neurosarcoidosis","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/RLU.0000000000002887","article-title":"FDG PET\/CT findings of ectopic pituitary adenoma","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/RLU.0000000000002776","article-title":"FDG PET\/CT image for a Rosai-Dorfman disease with pituitary and bone involvement in a pediatric patient","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12020-019-01944-7","article-title":"CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing\u2019s disease","volume":"65","year":"2019","journal-title":"Endocrine"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1097\/RLU.0000000000002202","article-title":"18F-FDOPA uptake reflects the efficacy of dopamine agonists treatment in pituitary prolactinoma","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1097\/RLU.0000000000002514","article-title":"Therapeutic response to rituximab in IgG4-related hypophysitis evidenced on 18F-FDG PET and MRI","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/RLU.0000000000000457","article-title":"Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy","volume":"39","year":"2014","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:03:44Z","timestamp":1750536224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003710","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,5,25]]}}}